Schizoaffective Disorders Completed Phase 4 Trials for Atomoxetine (DB00289)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00222794A Clinical Trial to Examine Effects of Atomoxetine in the Treatment of Negative Symptoms in Patients With SchizophreniaTreatment